Publicaciones en colaboración con investigadores/as de University of Verona (3)

2021

  1. Safety and activity of the TGFβ receptor i kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

2018

  1. Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

    British Journal of Cancer, Vol. 119, Núm. 10, pp. 1208-1214

2014

  1. Molecular biology of neuroendocrine tumors: From pathways to biomarkers and targets

    Cancer and Metastasis Reviews, Vol. 33, Núm. 1, pp. 345-351